Molekule Group, Inc.
MKULQ
OTC PK
| Weiss Ratings | MKULQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | MKULQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | MKULQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 2.13 | |||
| Price History | MKULQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | 0.00% | |||
| 2-Year Total Return | -99.98% | |||
| 3-Year Total Return | -99.99% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | 0.00% | |||
| 52-Week Low % Change | 33.33% | |||
| Price | MKULQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Mar 13, 2025 | |||
| 52-Week High Price (Date) | Mar 13, 2025 | |||
| Valuation | MKULQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | -- | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.01 | |||
| Earnings Per Share Growth | 20.96% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.00 | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | 1.93 | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -1.37 | |||
| Enterprise Value/EBIT | -1.31 | |||
| Market Cap Category | -- | |||
| Dividends and Shares | MKULQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 33.02M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | MKULQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 833 652 5326 | |||
| Address | 10455 Riverside Drive Palm Beach Gardens, FL 33410 | |||
| Website | molekule.com | |||
| Country | United States | |||
| Year Founded | 2011 | |||
| Profitability | MKULQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -146.76% | |||
| Profit Margin | -153.25% | |||
| Management Effectiveness | MKULQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -25.18% | |||
| Return on Equity | -- | |||
| Income Statement | MKULQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 21.74M | |||
| Total Revenue (TTM) | 21.74M | |||
| Revenue Per Share | $0.66 | |||
| Gross Profit (TTM) | 8.23M | |||
| EBITDA (TTM) | -30.57M | |||
| EBIT (TTM) | -31.91M | |||
| Net Income (TTM) | -33.32M | |||
| Net Income Avl. to Common (TTM) | -33.32M | |||
| Total Revenue Growth (Q YOY) | 18,578.42% | |||
| Earnings Growth (Q YOY) | -382.75% | |||
| EPS Diluted (TTM) | -1.01 | |||
| EPS Diluted Growth (Q YOY) | -104.14% | |||
| Balance Sheet | MKULQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 5.27M | |||
| Cash Per Share (Q) | $0.16 | |||
| Total Current Assets (Q) | 39.34M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 40.71M | |||
| Current Ratio (Q) | 2.275 | |||
| Book Value Per Share (Q) | $1.20 | |||
| Total Assets (Q) | 125.44M | |||
| Total Current Liabilities (Q) | 17.30M | |||
| Total Debt (Q) | 47.16M | |||
| Total Liabilities (Q) | 84.74M | |||
| Total Common Equity (Q) | 40.71M | |||
| Cash Flow | MKULQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 1.44M | |||
| Cash from Financing (TTM) | 8.95M | |||
| Net Change in Cash (TTM) | -23.26M | |||
| Levered Free Cash Flow (TTM) | -39.51M | |||
| Cash from Operations (TTM) | -33.66M | |||
